Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA Share Price    (TORR)

Here is the latest stock price and chart of Torrent Pharma. For more details, see the Torrent Pharma company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.

Top Stock to Buy: One stock with crorepati potential

REFRESH
Live BSE Quotes Jul 15, 2020 (Close)
Price (Rs)2,391.75 Open (Rs) 2,425.25 High (Rs) 2,450.00 Low (Rs) 2,382.20
% Change-1.18 Volume 14,548 Value (Rs) 35,152,848 52-Week H/L 2,679.45 / 1,453.00
Live NSE Quotes Jul 15, 2020 (Close)
Price (Rs)2,392.70 Open (Rs) 2,440.00 High (Rs) 2,451.30 Low (Rs) 2,380.25
% Change-1.18 Volume 448,134 Value (Rs) 1,084,327,302 52-Week H/L 2,699.00 / 1,452.00
Change
1 Day
-1.18%
1 Month
-2.62%
3 Months
4.01%
1 Year
54.06%
5 Years (CAGR)*
12.62%
10 Years (CAGR)*
23.70%

* Compound Annual Growth Rate

Valuation
EPS (Rs)* 60.56 P/E Ratio (x) 39.50 Market Cap (Rs m) 404,827.61 P/BV (x) 8.57
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
Loading...
 
Peer Group:
Quote & Graph
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new
Charts by TradingView

TORRENT PHARMA Share Price Today:

TORRENT PHARMA last traded price was down 1.2% to Rs 2,391.8 on the BSE. On the NSE, TORRENT PHARMA last traded price was down 1.2% to Rs 2,392.7. The total volume of shares traded was 0.5 m.

Overall, the broader S&P BSE HEALTHCARE Index was up by 0.5%. And the benchmark S&P BSE SENSEX was at 36,051.8 (up 0.1%).

Over the last 30 days, the TORRENT PHARMA share price is down 2.6%. And over the last one year, TORRENT PHARMA share price is up 54.1%.



What else is happening in the markets today? Dig in...


Today's Market

Sensex Falls 750 Points from Day's High; Telecom and Energy Stocks Witness Selling(Closing)

After opening the day on a strong note, Indian share markets witnessed selling pressure during closing hours today and ended flat.

Related Views On News

TORRENT PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 2.0% (Quarterly Result Update)

Jan 28, 2020 | Updated on Jan 28, 2020

For the quarter ended December 2019, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 2.0% YoY). Sales on the other hand came in at Rs 20 bn (down 4.1% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 36.3% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 36.3% YoY). Sales on the other hand came in at Rs 20 bn (up 5.9% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1 (Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Two Agri Stocks Are Likely to Outperform Even in this Market (Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

Smallcaps Are in a Sweet Spot Again: Are You Buying? (Profit Hunter)

Jul 3, 2020

This is why I believe smallcaps are the place to be in the near future.

How We Made 10%+ Profits Overnight (Fast Profits Daily)

Jul 3, 2020

A simple trade in natural gas delivered more than 10% overnight. Here's how we did it...

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA 8-QTR ANALYSIS

COMPARE TORRENT PHARMA WITH

MARKET STATS